SCHEMBL6022221

SCHEMBL6022221

O=C(CCOC(=O)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1)NCc1cccc(CNCCc2ccc(O)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.39
TRPV1 Q8NER1 3/20 0.38
ERCC1 P07992 1/20 0.38
ERCC4 Q92889 1/20 0.38
SLC2A1 P11166 1/20 0.37
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36
ITGB7 P26010 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
HTR5A P47898 1/20 0.34
HTR1A P08908 2/20 0.34
DRD2 P14416 2/20 0.34
HTR7 P34969 2/20 0.34
HTR6 P50406 2/20 0.34
PDCD1 Q15116 2/20 0.34
CD274 Q9NZQ7 2/20 0.34
ADRB2 P07550 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021934 0.88 MEN1 (0.40) BCHETRPV1ITGB1ITGA4ITGB7
SCHEMBL6027362 0.85 TRPV1 (0.39) BCHETRPV1SLC2A1ITGB1ITGA4
SCHEMBL6027475 0.85 TRPV1 (0.37) TRPV1ERCC1ERCC4HTR1ADRD2
SCHEMBL6021946 0.85 TRPV1 (0.47) TRPV1
SCHEMBL6022017 0.84 HTR1A (0.36) TRPV1HTR5AHTR1ADRD2HTR7
SCHEMBL6021982 0.82 ALDH1A1 (0.39) BCHETRPV1ADRB2CHRM3
SCHEMBL6027383 0.81 OPRM1 (0.36) BCHESLC2A1ITGB1ITGA4ITGB7
SCHEMBL4695551 0.81 CNR2 (0.40) TRPV1HTR1ADRD2HTR7HTR6
SCHEMBL6022468 0.81 ADRB2 (0.43) TRPV1ERCC1ERCC4DRD2ADRB2
SCHEMBL5247685 0.80 OPRK1 (0.37) TRPV1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723110-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2006-11-22 EP disclosed
WO-2005087735-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2005-09-22 WO disclosed